Evidence map›Paper›PMID 38937953›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2024

Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.

Nils Graber, Nina Canova, Denise Bryant-Lukosius, Glenn Robert, Blanca Navarro-Rodrigo, Lionel Trueb, George Coukos, Manuela Eicher, Tourane Corbière, Sara Colomer-Lahiguera

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Transforming Community-Based Rehabilitation Services: A National Redesign Using Experience-Based Co-Design.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  2. Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nils GraberInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Nina CanovaInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Denise Bryant-LukosiusSchool of Nursing and Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Glenn RobertFlorence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.ORCID 0000-0001-8781-6675
Blanca Navarro-RodrigoDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Lionel TruebDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
George CoukosDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Manuela EicherInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Tourane CorbièreInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Sara Colomer-LahigueraInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.ORCID 0000-0003-2390-5198

Funding

ISREC FoundationSwiss Cancer Research Foundation KFS-5649-08-2022
6 · The paper itself

Abstract

backgroundExperience-Based Co-Design (EBCD) is a multi-stage participatory action research process which was developed originally to increase patient involvement in service improvement initiatives. This viewpoint article serves as a reflection on the researchers' experiences, focusing on the application and feasibility of participatory approaches, particularly co-design, in the specific context of early-phase clinical trials.

methodsWe reflect on the opportunities and challenges of applying EBCD in a new context of early-phase clinical trials in oncology where experimental treatments are increasingly perceived as a therapeutic option and, in certain instances, their efficacy may lead to accelerated approval facilitating a swifter integration into standard care.

resultsWe propose that the opportunity of applying EBCD in such trials lies in improving the delivery of person-centered care, care coordination, and support during the transition from experimental to standard care. Three potential challenges when applying EBCD in early-phase clinical trials are discussed related to: the need for standardization in trial processes; planning EBCD in a context of high uncertainty; and vulnerability of patient populations.

conclusionIntegrating EBCD into early-phase oncology trials presents an opportunity to enhance person-centered care and can lead to simultaneous improvements in care processes and therapeutic development. PATIENT OR PUBLIC CONTRIBUTION: This article has been developed with the collaboration of a patient partner who serves on the advisory board of our ongoing EBCD study in early clinical trials.

Indexed as

Medical OncologyResearch DesignClinical Trials, Phase I as TopicHealth Services ResearchHumansNeoplasmsPatient-Centered CarePatient Participationearly‐phase clinical trialexperience‐based co‐designoncology

Identifiers

PMID38937953
PMCPMC11211206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.